Literature DB >> 26773182

Prevalence of and risk factors for high-risk human papillomavirus infection: a population-based study from Hetian, Xinjiang, China.

Mayinuer Niyazi1, Sulaiya Husaiyin, Lili Han, Huduyum Mamat, Kundus Husaiyin, Lin Wang.   

Abstract

Human papillomavirus (HPV) infection contributes to most cases of cervical cancer, and HPV genotypes exhibit different distributions according to geographic region. This study evaluates the prevalence of HPV infection in Hetian Prefecture, Xinjiang, and establishes risk factors associated with high-risk HPV (HR-HPV) genotypes in this region. In this cross-sectional, population-based study, 883 healthy women 15-54 years of age were enrolled. All participants completed a questionnaire regarding sociocultural and sexual activity characteristics. Visual inspections with acetic acid, colposcopies and biopsies were performed using the Preventive Oncology International microbiopsy protocol for pathological diagnosis. Cervical epithelial tissue specimens were collected and tested for HPV using linear array assays. According to the results of HR-HPV infection status, individuals infected with HR-HPV were classified into one group, and the remaining individuals were classified into the control group. The risk factors for HR-HPF infection were analyzed. The participants included 66 women (7.47%) with HR-HPV, 10 women (1.13%) with low-risk HPV, and 14 women (1.59%) with HPV of unknown risk. The five most prevalent types of HR-HPV were HPV-16 (0.31%), HPV-51 (0.08%), HPV-31 (0.07%), HPV-58 (0.07%), and HPV-39 (0.06%). Vulvovaginal ulcers and vulvovaginal inflammation were found in 190 participants (21.52%) and 256 participants (28.99%), respectively. The HR-HPV and control groups significantly differed with respect to age at first marriage, number of marriages, and the presence of vulvovaginal ulcers and vulvovaginal inflammation (p<0.05). Based on this study, an immunization strategy targeting HPV-16 should be prioritized in Hetian Prefecture. These findings contribute to the understanding of HPV infection.

Entities:  

Mesh:

Year:  2016        PMID: 26773182      PMCID: PMC4765939          DOI: 10.17305/bjbms.2016.593

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  21 in total

Review 1.  A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types.

Authors:  Davit Bzhalava; Peng Guan; Silvia Franceschi; Joakim Dillner; Gary Clifford
Journal:  Virology       Date:  2013-08-05       Impact factor: 3.616

2.  Knowledge, Behavioral, and Sociocultural Factors Related to Human Papillomavirus Infection and Cervical Cancer Screening Among Inner-City Women in Panama.

Authors:  Cheryl A Vamos; Arlene E Calvo; Ellen M Daley; Anna R Giuliano; Humberto López Castillo
Journal:  J Community Health       Date:  2015-12

3.  Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.

Authors:  Mark H Stoler; R Marshall Austin; Chengquan Zhao
Journal:  J Clin Microbiol       Date:  2015-05-06       Impact factor: 5.948

Review 4.  Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Authors:  Paul Appleby; Valerie Beral; Amy Berrington de González; Didier Colin; Silvia Franceschi; Adrian Goodhill; Jane Green; Julian Peto; Martyn Plummer; Siân Sweetland
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

5.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

6.  Cancer in developing countries.

Authors:  P Boffetta; D M Parkin
Journal:  CA Cancer J Clin       Date:  1994 Mar-Apr       Impact factor: 508.702

Review 7.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

Review 8.  Epidemiology of cervical cancer with special focus on India.

Authors:  Aswathy Sreedevi; Reshma Javed; Avani Dinesh
Journal:  Int J Womens Health       Date:  2015-04-16

9.  Risk factors for high-risk and multi-type Human Papillomavirus infections among women in Ho Chi Minh City, Vietnam: a cross-sectional study.

Authors:  Ly Thi-Hai Tran; Loi Thi Tran; Thanh Cong Bui; Dung Thi-Kieu Le; Alan G Nyitray; Christine M Markham; Michael D Swartz; Chau Bao Vu-Tran; Lu-Yu Hwang
Journal:  BMC Womens Health       Date:  2015-02-21       Impact factor: 2.809

10.  Human papillomavirus infection in Beijing, People's Republic of China: a population-based study.

Authors:  R Zhao; W Y Zhang; M H Wu; S W Zhang; J Pan; L Zhu; Y P Zhang; H Li; Y S Gu; X Z Liu
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more
  7 in total

1.  Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland.

Authors:  Themba G Ginindza; Xolisile Dlamini; Maribel Almonte; Rolando Herrero; Pauline E Jolly; Joyce M Tsoka-Gwegweni; Elisabete Weiderpass; Nathalie Broutet; Benn Sartorius
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

2.  Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland.

Authors:  Themba G Ginindza; Cristina D Stefan; Joyce M Tsoka-Gwegweni; Xolisile Dlamini; Pauline E Jolly; Elisabete Weiderpass; Nathalie Broutet; Benn Sartorius
Journal:  Infect Agent Cancer       Date:  2017-05-25       Impact factor: 2.965

3.  Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients

Authors:  Zeinab K Hassan; Mohamed M Hafez; Mahmoud M Kamel; Abdel Rahman N Zekri
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

4.  CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.

Authors:  Aiqin He; Jia Shao; Yu Zhang; Hong Lu; Zhijun Wu; Yunzhao Xu
Journal:  Oncotarget       Date:  2017-05-16

5.  Risk Factors for Endometrial Cancer: Results from a Hospital-Based Case-Control Study

Authors:  Maryam Ghanbari Andarieh; Mouloud Agajani Delavar; Dariush Moslemi; Sedighe Esmaeilzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

6.  Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.

Authors:  Sulaiya Husaiyin; Lili Han; Lin Wang; Chunhua Ma; Zumurelaiti Ainiwaer; Nuermanguli Rouzi; Mireguli Akemujiang; Hatiguli Simayil; Zumulaiti Aniwa; Rouzi Nurimanguli; Mayinuer Niyazi
Journal:  BMC Cancer       Date:  2018-11-23       Impact factor: 4.430

7.  The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Authors:  Dabao Xu; Xingping Zhao; Bingsi Gao; Yu-Ligh Liou; Yang Yu; Lingxiao Zou; Waixing Li; Huan Huang; Aiqian Zhang
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.